- UTHR has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $144.9 million.
- UTHR has traded 6,518 shares today.
- UTHR is trading at a new lifetime high.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in UTHR with the Ticky from Trade-Ideas. See the FREE profile for UTHR NOW at Trade-Ideas More details on UTHR: United Therapeutics Corporation, a biotechnology company, develops and commercializes products to address the unmet medical needs of patients with chronic and life-threatening conditions worldwide. UTHR has a PE ratio of 24.4. Currently there are 4 analysts that rate United Therapeutics a buy, no analysts rate it a sell, and 5 rate it a hold. The average volume for United Therapeutics has been 836,600 shares per day over the past 30 days. United has a market cap of $5.9 billion and is part of the health care sector and drugs industry. The stock has a beta of 1.57 and a short float of 16.5% with 4.30 days to cover. Shares are up 11.9% year-to-date as of the close of trading on Monday. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.